Wagner R, Daehnert I, Lurz P. Percutaneous pulmonary and tricuspid valve implantations: An update. World J Cardiol 2015; 7(4): 167-177 [PMID: 25914786 DOI: 10.4330/wjc.v7.i4.167]
Corresponding Author of This Article
Philipp Lurz, MD, PhD, Department of Internal Medicine/Cardiology, University of Leipzig-Heart Center, Struempellstrasse 39, D-04289 Leipzig, Germany. philipp.lurz@gmx.de
Research Domain of This Article
Cardiac & Cardiovascular Systems
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Cardiol. Apr 26, 2015; 7(4): 167-177 Published online Apr 26, 2015. doi: 10.4330/wjc.v7.i4.167
Percutaneous pulmonary and tricuspid valve implantations: An update
Robert Wagner, Ingo Daehnert, Philipp Lurz
Robert Wagner, Ingo Daehnert, Department of Paediatric Cardiology, University of Leipzig-Heart Center, D-04289 Leipzig, Germany
Philipp Lurz, Department of Internal Medicine/Cardiology, University of Leipzig-Heart Center, D-04289 Leipzig, Germany
Author contributions: All authors contributed to this work.
Conflict-of-interest: Wagner R reports no conflict of interest. Daehnert I is a proctor for Melody-PPVI (Medtronic). Lurz P is a consultant to Medtronic and has received fees for serving as a speaker.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Philipp Lurz, MD, PhD, Department of Internal Medicine/Cardiology, University of Leipzig-Heart Center, Struempellstrasse 39, D-04289 Leipzig, Germany. philipp.lurz@gmx.de
Telephone: +49-341-865251428 Fax: +49-341-8651461
Received: October 28, 2014 Peer-review started: October 30, 2014 First decision: December 12, 2014 Revised: February 6, 2015 Accepted: February 10, 2015 Article in press: February 12, 2015 Published online: April 26, 2015 Processing time: 173 Days and 15 Hours
Core Tip
Core tip: The field of percutaneous valve implantation/repair is rapidly developing within interventional cardiology. Percutaneous procedures focusing on aortic, mitral or pulmonary valve dysfunction have almost reached daily routine. In contrast, percutaneous treatment of tricuspid valve dysfunction is still evolving on a much earlier level. Taking into account that an “interdisciplinary challenging” population of patients previously treated by corrective, semi-corrective or palliative surgery is growing inexorably, there is an increasing need of options besides redo-surgery. This review intends to report on clinical application of pulmonary and tricuspid valve procedures. It updates on current devices, patient selection criteria, results and future directions.
